icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
June 22-26 2022
Back grey_arrow_rt.gif
 
 
 
EDP-514, a Novel Pangenotypic Class II Hepatitis B Virus
Core Inhibitor: Results of a 28-day Phase 1b Study in NUC-suppressed CHB Patients

 
 
  EASL 2022 June 22-26

0906221

0906222

0906223

0906224

0906225

0906226

0906227

0906228